The schizophrenia syndrome, circa 2024: What we know and how that informs its nature
R Tandon, H Nasrallah, S Akbarian… - Schizophrenia …, 2024 - Elsevier
With new data about different aspects of schizophrenia being continually generated, it
becomes necessary to periodically revisit exactly what we know. Along with a need to review …
becomes necessary to periodically revisit exactly what we know. Along with a need to review …
[HTML][HTML] Half a century of research on antipsychotics and schizophrenia: A scientometric study of hotspots, nodes, bursts, and trends
Abstract Changes over 50 years of research on antipsychotics in schizophrenia have
occurred. A scientometric synthesis of such changes over time and a measure of …
occurred. A scientometric synthesis of such changes over time and a measure of …
Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors
People with schizophrenia die 15‐20 years prematurely. Understanding mortality risk and
aggravating/attenuating factors is essential to reduce this gap. We conducted a systematic …
aggravating/attenuating factors is essential to reduce this gap. We conducted a systematic …
Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo …
Background Emraclidine is a novel, brain-penetrant, highly selective M4 receptor positive
allosteric modulator in development for the treatment of schizophrenia. We aimed to …
allosteric modulator in development for the treatment of schizophrenia. We aimed to …
European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part III: pharmacological treatment
V Roessner, H Eichele, JS Stern, L Skov… - European child & …, 2022 - Springer
Abstract In 2011, the European Society for the Study of Tourette Syndrome (ESSTS)
published the first European guidelines for Tourette Syndrome (TS). We now present an …
published the first European guidelines for Tourette Syndrome (TS). We now present an …
Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics
Clinical practice guidelines (CPGs) translate evidence into recommendations to improve
patient care and outcomes. To provide an overview of schizophrenia CPGs, we conducted a …
patient care and outcomes. To provide an overview of schizophrenia CPGs, we conducted a …
Atypical antipsychotics and metabolic syndrome: from molecular mechanisms to clinical differences
Atypical antipsychotics (AAPs) are commonly prescribed medications to treat schizophrenia,
bipolar disorders and other psychotic disorders. However, they might cause metabolic …
bipolar disorders and other psychotic disorders. However, they might cause metabolic …
A guideline and checklist for initiating and managing clozapine treatment in patients with treatment-resistant schizophrenia
Abstract Treatment-resistant schizophrenia (TRS) will affect about one in three patients with
schizophrenia. Clozapine is the only treatment approved for TRS, and patients should be …
schizophrenia. Clozapine is the only treatment approved for TRS, and patients should be …
Efficacy and safety of clozapine in psychotic disorders—a systematic quantitative meta-review
A recent increase in the literature regarding the evidence base for clozapine has made it
increasingly difficult for clinicians to judge “best evidence” for clozapine use. As such, we …
increasingly difficult for clinicians to judge “best evidence” for clozapine use. As such, we …
[HTML][HTML] The ketogenic diet for refractory mental illness: a retrospective analysis of 31 inpatients
A Danan, EC Westman, LR Saslow, G Ede - Frontiers in psychiatry, 2022 - frontiersin.org
Background and Hypothesis The robust evidence base supporting the therapeutic benefit of
ketogenic diets in epilepsy and other neurological conditions suggests this same metabolic …
ketogenic diets in epilepsy and other neurological conditions suggests this same metabolic …